A citation-based method for searching scientific literature

Dong Chen, Zixian Jin, Jian Zhang, Congcong Xu, Kanghao Zhu, Yuhang Ruan, Bo Zhang, Baofu Chen, Jianfei Shen. Front Surg 2021
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato,[...]. N Engl J Med 2020
418
66

BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.
Yuri Sheikine, Dean Pavlick, Samuel J Klempner, Sally E Trabucco, Jon H Chung, Mark Rosenzweig, Kai Wang, Vamsidhar Velcheti, Garrett M Frampton, Nir Peled,[...]. JCO Precis Oncol 2018
18
33

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.
Kartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, Francis J Giles, Barbara J Gitlitz, Kyle Gowen, Eiki Ichihara, Taofeek K Owonikoko, Vijay Peddareddigari, Suresh S Ramalingam,[...]. Cancer Discov 2016
66
33

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
Shinkichi Takamori, Taichi Matsubara, Naoki Haratake, Gouji Toyokawa, Takatoshi Fujishita, Ryo Toyozawa, Kensaku Ito, Masafumi Yamaguchi, Kenichi Taguchi, Tatsuro Okamoto,[...]. Front Oncol 2021
2
50

A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
Soo-Ryum Yang, Umut Aypar, Ezra Y Rosen, Douglas A Mata, Ryma Benayed, Kerry Mullaney, Gowtham Jayakumaran, Yanming Zhang, Denise Frosina, Alexander Drilon,[...]. Clin Cancer Res 2021
16
33

The Promising Evolution of Targeted Therapeutic Strategies in Cancer.
Solange Peters, Tony Mok, Antonio Passaro, Pasi Antero Jänne. Cancer Discov 2021
5
33

Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report.
Cheng-You Wang, Jiun-Yi Hsia, Che-Hsing Li, Chao-Chi Ho, Wan-Ru Chao, Ming-Fang Wu. Clin Lung Cancer 2021
2
50

The transcriptional landscape and mutational profile of lung adenocarcinoma.
Jeong-Sun Seo, Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, June Koo Lee, Thomas Bleazard, Junho Lee, Yoo Jin Jung, Jung-Oh Kim, Jung-Young Shin,[...]. Genome Res 2012
408
33

A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib.
You-Cai Zhu, Wen-Xian Wang, Chun-Wei Xu, Wu Zhuang, Kai-Qi Du, Gang Chen, Tang-Feng Lv, Yong Song. Clin Lung Cancer 2019
7
33

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement.
Jan Budczies, Daniel Kazdal, Michael Allgäuer, Petros Christopoulos, Eugen Rempel, Nicole Pfarr, Wilko Weichert, Stefan Fröhling, Michael Thomas, Solange Peters,[...]. Lung Cancer 2020
15
33

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J Piper-Vallillo, Hollis Viray, Adeel M Khan, Deepa Rangachari, Daniel B Costa. Precis Cancer Med 2020
10
33

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
James P Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y Rosen, Denise Frosina, Achim A Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon,[...]. Mod Pathol 2020
202
33


NUT carcinoma of the lung.
Sylvie Lantuejoul, Daniel Pissaloux, Gilbert R Ferretti, Anne McLeer. Semin Diagn Pathol 2021
2
50

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.
Esther Conde, Federico Rojo, Javier Gómez, Ana Belén Enguita, Ihab Abdulkader, Ana González, Dolores Lozano, Nuria Mancheño, Clara Salas, Marta Salido,[...]. J Clin Pathol 2022
7
33

How selecting best upfront therapy for metastatic disease?-Focus on ROS1-rearranged disease.
Lorenza Landi, Federico Cappuzzo. Transl Lung Cancer Res 2020
3
33

Supercharging BRD4 with NUT in carcinoma.
Kyle P Eagen, Christopher A French. Oncogene 2021
13
33

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas.
Matthias S Matter, Obinna Chijioke, Spasenija Savic, Lukas Bubendorf. Transl Lung Cancer Res 2020
9
33

ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors.
Helene Doubre, Severine Fraboulet, Elisabeth Longchampt, Diane Damotte, Audrey Lupo, Louis-Jean Couderc, Matthieu Glorion, Segolene Hescot. Clin Lung Cancer 2021
2
50

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay.
Simon Heeke, Jonathan Benzaquen, Audrey Vallee, Maryline Allegra, Julien Mazieres, Julien Fayada, Jaya Rajamani, Michael Lee, Ellen Ordinario, Angelica Tiotiu,[...]. Ann Transl Med 2021
3
33

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.
Alice Guyard, Alice Boyez, Anaïs Pujals, Cyrielle Robe, Jeanne Tran Van Nhieu, Yves Allory, Julien Moroch, Odette Georges, Jean-Christophe Fournet, Elie-Serge Zafrani,[...]. Virchows Arch 2017
50
33

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.
Caterina De Luca, Francesco Pepe, Antonino Iaccarino, Pasquale Pisapia, Luisella Righi, Angela Listì, Lorenza Greco, Gianluca Gragnano, Severo Campione, Gianfranco De Dominicis,[...]. Cancers (Basel) 2021
9
33

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
35
33

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.
Angel Qin, Adrienne Johnson, Jeffrey S Ross, Vincent A Miller, Siraj M Ali, Alexa B Schrock, Shirish M Gadgeel. J Thorac Oncol 2019
39
33

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis.
Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, Simone Bauer, Florian Janke, Simon John Ogrodnik, Martin Reck, Matthias Schlesner, Michael Meister, Marc A Schneider,[...]. NPJ Precis Oncol 2021
4
33

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer.
Mark Kriegsmann, Christian Haag, Cleo-Aron Weis, Georg Steinbuss, Arne Warth, Christiane Zgorzelski, Thomas Muley, Hauke Winter, Martin E Eichhorn, Florian Eichhorn,[...]. Cancers (Basel) 2020
18
33

Artificial intelligence as the next step towards precision pathology.
B Acs, M Rantalainen, J Hartman. J Intern Med 2020
77
33

Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, Stephan Rheinheimer, Daniel Kazdal, Anna-Lena Volckmar, Florian Janke, Volker Endris, Michael Meister, Mark Kriegsmann,[...]. Transl Lung Cancer Res 2021
9
33

A Catalog of 5' Fusion Partners in ROS1-Positive NSCLC Circa 2020.
Sai-Hong Ignatius Ou, Misako Nagasaka. JTO Clin Res Rep 2020
4
33

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Julianna G Supplee, Marina S D Milan, Lee P Lim, Kristy T Potts, Lynette M Sholl, Geoffrey R Oxnard, Cloud P Paweletz. Lung Cancer 2019
48
33

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J Herth, Hauke Winter,[...]. Cancer Immunol Immunother 2022
6
33


Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?
Nobuaki Ochi, Hiromichi Yamane, Tomoko Yamagishi, Nagio Takigawa, Yasumasa Monobe. Lung Cancer 2013
10
33

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
3
33

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.
Alexander Drilon, Michael Duruisseaux, Ji-Youn Han, Masaoki Ito, Christina Falcon, Soo-Ryum Yang, Yonina R Murciano-Goroff, Haiquan Chen, Morihito Okada, Miguel Angel Molina,[...]. J Clin Oncol 2021
10
33

Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Richard S P Huang, James Haberberger, Ethan Sokol, Alexa B Schrock, Natalie Danziger, Russell Madison, Sally Trabucco, Dexter Jin, Dean Pavlick, Vivek Ramanan,[...]. Int J Cancer 2021
7
33

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma.
Hui Xu, Chuan Shao. Onco Targets Ther 2020
7
33

Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.
Yunjian Pan, Yang Zhang, Ting Ye, Yue Zhao, Zhendong Gao, Hui Yuan, Difan Zheng, Shanbo Zheng, Hang Li, Yuan Li,[...]. J Thorac Oncol 2019
36
33

Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer.
Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A Schneider,[...]. Cold Spring Harb Mol Case Stud 2019
10
33

FGFR3-TACC3 fusion in solid tumors: mini review.
Ricardo Costa, Benedito A Carneiro, Timothy Taxter, Fabio A Tavora, Aparna Kalyan, Sachin A Pai, Young Kwang Chae, Francis J Giles. Oncotarget 2016
72
33

Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.
Patricia J T A Groenen, Willeke A M Blokx, Coos Diepenbroek, Lambert Burgers, Franco Visinoni, Pieter Wesseling, Johan H J M van Krieken. Histopathology 2011
35
33

The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
359
33

Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer.
Ziming Li, Lan Shen, Ding Ding, Jia Huang, Jie Zhang, Zhiwei Chen, Shun Lu. J Thorac Oncol 2018
45
33

The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients.
Lei Cai, Yong Chen, Xiaoling Tong, Xue Wu, Hua Bao, Yang Shao, Zhuang Luo, Xuming Wang, Yang Cao. Int J Cancer 2021
4
33

Challenges and Opportunities in NUT Carcinoma Research.
Maxwell C Hakun, Bin Gu. Genes (Basel) 2021
2
50

Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung.
Christina Alidousty, Nicolai Duerbaum, Svenja Wagener-Ryczek, Till Baar, Luciano G Martelotto, Carina Heydt, Janna Siemanowski, Barbara Holz, Elke Binot, Jana Fassunke,[...]. Histopathology 2021
3
33

NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
Martina Kirchner, Julia Glade, Ulrich Lehmann, Sabine Merkelbach-Bruse, Michael Hummel, Annika Lehmann, Marcel Trautmann, Jörg Kumbrink, Andreas Jung, Wolfgang Dietmaier,[...]. Genes Chromosomes Cancer 2020
16
33

Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.
Steffen Dietz, Alexander Harms, Volker Endris, Florian Eichhorn, Mark Kriegsmann, Rémi Longuespée, Albrecht Stenzinger, Holger Sültmann, Arne Warth, Daniel Kazdal. Int J Cancer 2017
15
33


Identification of targetable FGFR gene fusions in diverse cancers.
Yi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, Nickolay Khazanov, Bushra Ateeq, Xuhong Cao, Robert J Lonigro, Pankaj Vats, Rui Wang, Su-Fang Lin,[...]. Cancer Discov 2013
486
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.